ISMIE Risk Management invites you to their event

The Triple Wave Epidemic: Opioid Pills, Heroin and Fentanyl

Thursday, March 10th 2022 - 6:00 PM (GMT)

The event is over. See you in the next one.

About this event

The U.S. is currently experiencing a historic and continuously expanding 20+ year drug overdose problem. In this presentation, Dan Ciccarone, MD, MPH, will describe the triple wave of opioid overdoses stemming from the expanding population use of opioid pills, heroin and synthetic opioids, including fentanyls. He will also discuss the epidemiology and geography of the overdose phenomenon, along with the supply and demand drivers of opioid use. And finally, he will touch upon new phenomena, including COVID-19’s impact on the opioid epidemic, the expansion of fentanyls into new geographic areas, as well as co-use of fentanyls and methamphetamine (aka the “fourth wave”).

Who can attend

Registration is limited to ISMIE and SEMPIC policyholders and their employed staff.

Learning objectives

At the conclusion of this learning activity, participants will be able to:

  • Summarize national data on opioid, heroin and fentanyl overdose
  • Discuss the supply and demand forces behind the triple wave
  • Identify the impact COVID-19 has had on the opioid epidemic
  • Describe the issues related to the increase in use of fentanyl in combination with other substances

About the presenter

Dr. Dan Ciccarone is the Justine Miner Professor in Addiction Medicine in the department of Family and Community Medicine at UCSF. He has been principal or co-investigator on numerous NIH sponsored public health research projects including his current Synthetics in Combination (SYNC) study. He is a recognized international scholar on the medical, public health and public policy dimensions of substance use, risks and consequences. He is Associate Editor for the International Journal of Drug Policy and recently edited an IJDP special issue on the “triple wave crisis” of opioids, heroin and fentanyl in the US. He consults for numerous private and public entities including the ONDCP, CDC and FDA.


Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Illinois State Medical Society and ISMIE Mutual Insurance Company. The Illinois State Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Illinois State Medical Society designates this live activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.

ISMIE Risk Management

Our Passion Protects Yours

ISMIE Mutual provides superior insurance services to medical practices and providers, delivering quality, value and protection to policyholders everywhere.